Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05988450

Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation

A Prospective, Multicenter, Single Arm Clinical Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Clip Delivery System and Steerable Guide Catheter in Patients With Moderate-severe or Severe Functional MR (FMR)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Shanghai Shenqi Medical Technology Co., Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To verify the safety and effectiveness of transcatheter mitral valve clip delivery system and steerable guide catheter produced by Shanghai Shenqi Medical Technology Co., Ltd. in patients with moderate-severe (3 +) or severe (4 +) functional MR (functional MR) who still have symptoms after full treatment.

Detailed description

This study is a prospective, multi-center, single arm clinical study designed to evaluate the safety and effectiveness of transcatheter mitral valve clip delivery system and steerable guide catheter in patients with moderate-severe (3 +) or severe (4 +) functional MR (Functional MR) who still have symptoms after adequate treatment. This trial will be conducted at 41 sites in China and is planned to include a total of 118 subjects. All subjects received the trial device for transcatheter mitral valve clip delivery system and steerable guide catheter, and were followed up at 30 days, 6 months, and 12 months after surgery. The composite endpoint of all-cause death and hospitalization for heart failure was assessed at 12 months after surgery. After the 12th month follow-up, the statistical analysis, clinical summary and application for product registration were carried out.

Conditions

Interventions

TypeNameDescription
DEVICESQ-Kyrin Transcatheter Mitral Valve Repair SystemTranscatheter mitral valve clip placement to repair the valve and correct regurgitation.

Timeline

Start date
2022-03-07
Primary completion
2023-12-01
Completion
2027-12-01
First posted
2023-08-14
Last updated
2023-08-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05988450. Inclusion in this directory is not an endorsement.